Aptimmune Launches World’s First Mucosal PRRSV Vaccine
with No Comments

CHAMPAIGN, Illinois (June 07, 2017) – Aptimmune Biologics has launched its first autogenous PRRSV vaccine made with BARRICADE® formulation technology. It’s the world’s first commercially available mucosal PRRSV vaccine for swine administered via nasal spray. Aptimmune’s autogenous mucosal PRRSV vaccine … Read More

Aptimmune Biologics Receives Iowa Biotech Innovation Showcase’s Top Company Award
with No Comments

Swine-vaccine developer recognized as Top Company at this year’s Partnering for Growth Biotech Innovation Showcase & Forum  CHAMPAIGN, Illinois (March 24, 2017) – Aptimmune Biologics was awarded this year’s Biotech Innovation Showcase’s Top Company Award at the 2017 Partnering for … Read More

Iowa State University and Aptimmune Join Forces to Improve PRRSV Isolation
with No Comments

CHAMPAIGN, Ill. (December 14, 2016) – The Iowa State University Veterinary Diagnostic Laboratory is teaming up with Aptimmune Biologics Inc. to develop innovative solutions to fight costly viral diseases of swine. The agreement enables Iowa State to use Aptimmune’s patented … Read More

Aptimmune Biologics Selected by The Yield Lab to Participate in Ag Technology Accelerator Program
with No Comments

Swine mucosal vaccine company received $100,000 in funding, plus networking, mentorship and other support CHAMPAIGN, Illinois (November 17, 2016) – Aptimmune Biologics was selected by The Yield Lab, a St. Louis-based agriculture technology business accelerator and investor, to participate in a … Read More

Aptimmune Uses Novel Technology to Fight Swine Pathogens
with No Comments

JAMIE JOHANSEN | AgWired | June 21, 2016 Just last year the small team raised their first round of funding and brought on CEO, Aaron Gilbertie, to help lead the company through the development, product registration and commercialization of Aptimmune’s … Read More

Aptimmune Offering New Vaccination Technology
with No Comments

SwineCast | July 12, 2016 Aptimmune Biologics is bringing new intra-nasal vaccination technology to the swine industry.  CEO Aaron Gilbertie discusses the company’s focus and products at World Pork Expo. Read More…

Swine Vaccine Maker at Ag Innovations Showcase
with No Comments

JULIE HARKER | Brownfield Ag News | September 21, 2016 A wide variety of ag innovators is asking for support at the Ag Innovations Showcase. A startup company that provides crickets for poultry feed, a tropical weather forecast provider for … Read More

Aptimmune Biologics Raises $2.75 Million of Series A Funding Led by Arsenal Capital Management
with No Comments

Company will create new swine vaccines based on advanced mucosal technology New CEO joins the company to drive development and commercialization CHAMPAIGN, Illinois – July 7, 2015 – Aptimmune Biologics, a mucosal vaccine company developing novel swine vaccines for PRRSV … Read More